Cargando…
Gd-metallofullerenol nanomaterial as non-toxic breast cancer stem cell-specific inhibitor
The contemporary use of nanomedicines for cancer treatment has been largely limited to serving as carriers for existing therapeutic agents. Here, we provide definitive evidence that, the metallofullerenol nanomaterial Gd@C(82)(OH)(22), while essentially not toxic to normal mammary epithelial cells,...
Autores principales: | Liu, Ying, Chen, Chunying, Qian, Pengxu, Lu, Xuefei, Sun, Baoyun, Zhang, Xiao, Wang, Liming, Gao, Xingfa, Li, Han, Chen, Zhiyun, Tang, Jinglong, Zhang, Weijie, Dong, Jinquan, Bai, Ru, Lobie, Peter E., Wu, Qingfa, Liu, Suling, Zhang, Huafeng, Zhao, Feng, Wicha, Max S., Zhu, Tao, Zhao, Yuliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Pub. Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4354030/ https://www.ncbi.nlm.nih.gov/pubmed/25612916 http://dx.doi.org/10.1038/ncomms6988 |
Ejemplares similares
-
A Novel Drug Design Strategy: An Inspiration from Encaging Tumor by Metallofullerenol Gd@C(82)(OH)(22)
por: Li, Jinxia, et al.
Publicado: (2019) -
Non-destructive Inhibition of Metallofullerenol Gd@C(82)(OH)(22) on WW domain: Implication on Signal Transduction Pathway
por: Kang, Seung-gu, et al.
Publicado: (2012) -
The Molecular Mechanism of Human Voltage-Dependent Anion Channel 1 Blockade by the Metallofullerenol Gd@C(82)(OH)(22): An In Silico Study
por: Wang, Xiuxiu, et al.
Publicado: (2022) -
Dual Inhibitory Pathways of Metallofullerenol Gd@C(82)(OH)(22) on Matrix Metalloproteinase-2: Molecular insight into drug-like nanomedicine
por: Kang, Seung-gu, et al.
Publicado: (2014) -
Ferroptosis: challenges and opportunities for nanomaterials in cancer therapy
por: Liu, Qiaolin, et al.
Publicado: (2023)